Representation of women in clinical trials supporting FDA‐approval of contemporary cancer therapies is a research paper published in International Journal of Cancer (2024). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health (NIH)
Grant: K12-CA133250
NHLBI NIH HHS
Grant: L30 HL148881
NCI NIH HHS
Grant: P30 CA016058
National Institutes of Health (NIH)
Grant: R01HL170038
NHLBI NIH HHS
Grant: R01 HL159216
NHLBI NIH HHS
Grant: R01 HL168045
NHLBI NIH HHS
Grant: K01 HL142848
National Institutes of Health (NIH)
Grant: KL2-TR002733
NCATS NIH HHS
Grant: UL1 TR002733
NCI NIH HHS
Grant: K12 CA133250
NHLBI NIH HHS
Grant: R56 HL159216
NHLBI NIH HHS
Grant: K23 HL155890
National Institutes of Health (NIH)
Grant: K23-HL155890
MeSH Terms
Keywords